Latest Dabigatran Stories
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
The report’s publication comes as dozens of people pursue Xarelto lawsuits for internal bleeding and other serious complications allegedly related to its use. New
Xarelto Bleeding Lawsuits Filed In Federal And State Courts Allege The Prescription Blood Thinner Causes Uncontrollable Or Fatal Bleeding Due To The Lack Of An Antidote Columbus,
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe
Multidistrict Litigation For Xarelto Bleeding Lawsuits That Allege Patients Experienced Uncontrollable Bleeding And Other Complications After Taking The Prescription Blood Thinner Has Been Established
NMSOAP collaboration with FDA to bring the “voice of patient” to the real-world evaluation of recently-approved medications Rockville, Md (PRWEB) December
- Phase I study results presented at American Society of Hematology Annual Meeting RIDGEFIELD, Conn., Dec. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
SAN FRANCISCO, Dec.
The Xarelto Lawsuit Complaint Alleges That Janssen Pharmaceuticals And Bayer HealthCare Did Not Disclose The Bleeding Risks Associated With The Prescription Blood Thinner Medication.
- In medieval musical notation, a sign or neume denoting a shake or trill.